Hi All -
I'll be starting at a respectable MBA program this year and will be in the fortunate position of having to decide between IBD or Sell Side Equity Research (Buy side would be ideal but taking a conservative approach)
So I was under the impression that IBD would open more doors generally, than Equity Research. I was willing to deal with the stress, the hours, and the work that can get a little repetitive with IBD if I could leave in a couple of years to do ER for a buy side investment firm or even go into PE. But apparently there is a regimented HF hiring timeframe for talent and that time period begins and ends with the Analyst program? Is this true? And if it is how reasonable is it for someone starting as Associate program at (GS,MS,JP) to get through to the buy side, PE or HF in a couple of years.
I guess my question is, is it better to just do Equity Research (take the pay cut with the better hours and more meaningful work) for a couple of years and then network into the buy side? The nature of sell side research work is much closer to what HF's do, coupled with the fact that you interact with Portfolio Managers on a regular basis, would it not stand to reason that sell side research is the better option between the two? Especially considering that the 'post-mba associate programs in IBD' seemingly have (fewer?) exit opps to the buy side.
Side Note: I see a lot of vitriol on this forum especially when there are dissenting views so please let's keep it civil
Thank you in advance